Breaks Categories: News

MondaySep 18, 2017 10:22 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Nets Total Proceeds of $11.9 Million from Exercise of Warrants

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has received total proceeds of nearly $11.9 million from the exercise of an aggregate of 19,185,965 warrants since the closing of its acquisition of ABcann Medicinals Inc. on April 28, 2017. With these funds, ABcann’s current cash position stands at approximately $45 million, giving the company the means to execute previously outlined plans to expand its production capabilities. “ABcann thanks our shareholders for their continued support and confidence as we work toward expanding our facilities and increasing production,” Aaron Keay, director and CEO of ABcann, stated in the…

Continue Reading

FridaySep 15, 2017 2:01 pm

CannabisNewsBreaks – Organigram (TSX.V: OGI) (OTCQB: OGRMF) Signs MOU with Canadian Provincial Authority for Distribution of Cannabis to Adult Recreational Market

Organigram Holdings Inc. (TSX.V: OGI) (OTCQB: OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, today announced it has entered into a memorandum of understanding (MOU) with the New Brunswick provincial authority for the distribution of marijuana to the adult-use recreational market. Through the MOU, New Brunswick secures a supply of at least five million grams of recreational marijuana per year from Organigram. In a news release, Organigram CEO Greg Engel said, “We applaud the New Brunswick government’s efforts to foster an innovative, forward-thinking economic climate that supports cannabis as a driver of growth for New…

Continue Reading

WednesdaySep 13, 2017 2:15 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Secures $20M Pre-IPO Financing Agreement

The Green Organic Dutchman Holdings Ltd. (“TGOD”) earlier this week announced a $20 million private placement with a syndicate led by PI Financial Corp., priced at C$1.65 per unit. Shares will have a six-month hold period from the day of the company’s initial public offering (IPO), which is anticipated in January of 2018. The medicinal cannabis producer said it plans to use the net proceeds to advance its facilities in Ontario and Quebec, as well as for working capital purposes. View the full press release at http://cnw.fm/WWP6b About The Green Organic Dutchman Ltd. The Green Organic Dutchman Ltd. grows high…

Continue Reading

WednesdaySep 13, 2017 2:14 pm

CannabisNewsBreaks – Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) Harvests First California Cannabis Crop

Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) recently announced the harvest of its first cannabis crop from its previously announced Riverside County, California, cultivation facility. The company is currently drying, curing, trimming and packaging the flower in preparation for sale and distribution to medical patients in California later this month. Future Farm estimates the harvest of approximately 90 pounds with a market value of $144,000-$180,000. A video of the cultivation facility, filmed in July, is also online and available for viewing. To view the full press release, visit http://cnw.fm/66Ajl About Future Farm Technologies Inc. Future Farm’s business model includes…

Continue Reading

TuesdaySep 12, 2017 9:54 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Files Provisional Patent Covering Proprietary Biosynthesis Program

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its filing of a provisional patent application pertaining to the company’s biosynthesis program for the manufacture of cannabinoids that are identical to those found in nature. Per the news release, this patent application, once converted into an international Patent Cooperation Treaty (PCT) application and pursued in key jurisdictions around the world, will offer significant commercial protections for InMed’s promising E. coli-based expression system, which enables the manufacture of any of the 90+ cannabinoid compounds found in the cannabis plant. “This novel approach to the biosynthesis of…

Continue Reading

MondaySep 11, 2017 1:11 pm

CannabisNewsBreaks – Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF) Accelerates its Cannabis-based Clinical Research Program in the Veterinary Market

Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF), a biopharmaceutical leader in cannabinoid-based drug discovery and development, is adding international expert Dr. Louis-Philippe de Lorimier, a board certified veterinary oncologist, to its clinical advisory board for the veterinary market. In a news release, Dr. Guy Chamberland, chief scientific officer of Tetra Bio-Pharma, said, "We are leveraging our current R&D work in humans to accelerate the development of the first cannabinoid-based drug for pets in the cancer-associated supportive therapy market, including pain. This market is underserved and patients and their owner are waiting for alternatives that are safer, more tolerable and more efficacious.”…

Continue Reading

MondaySep 11, 2017 12:20 pm

CannabisNewsBreaks – Terra Tech Corp. (TRTC) Files Provisional Patent Application for Cannabis-Infused Rolling Papers

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated, cannabis-focused agriculture company, has filed a patent application with the U.S. Patent and Trademark Office for innovative cannabis-infused rolling papers. Expected to launch in 2018, the inventive rolling papers will be the latest addition to the company’s portfolio of IVXX™ branded premium cannabis products, which includes flowers, concentrates, custom-rolled joints and edibles. As with all its products, the rolling papers will be free of toxic pesticides, harmful molds and chemical residues, the company states. In the news release, Derek Peterson, CEO of Terra Tech, said, “Infusing rolling papers with cannabis can enhance…

Continue Reading

ThursdaySep 07, 2017 1:09 pm

CannabisNewsBreaks – Organigram (TSX.V: OGI) (OTCQB: OGRMF) Enters into MOU for Microwave Assisted Extraction Technique Development

Organigram Holdings Inc. (TSX.V: OGI) (OTCQB: OGRMF) will jointly develop an industry leading method of microwave extraction of cannabinoid extracts from marijuana plants with the New Brunswick Innovation Research Chair in Medical Technologies (NBIRC), an initiative of the New Brunswick Innovation Fund (NBIF), it was announced Wednesday. A memorandum of understanding between Organigram Holdings Inc. and NBIRC details the project which will focus on developing a more efficient manner of extracting cannabinoids for use in extracts and edibles. The project will be led by Dr. J. R. Jocelyn Paré, holder of the NBIRC, the inventor of various Microwave-Assisted Processes forming…

Continue Reading

ThursdaySep 07, 2017 9:31 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Names Barry Fishman as New CEO

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the appointment of Barry Fishman as its new chief executive officer, effective October 1, 2017. Fishman brings nearly two decades of experience as a business leader to the ABcann team, having most recently served as CEO of international specialty pharmaceutical company Merus Labs. Under his leadership, Merus’s sales and EBITDA grew at a CAGR of greater than 50 percent, leading to the company’s acquisition by Norgine B.V. in July 2017 for total considerations of roughly $342 million. “Barry's proven experience as a CEO of complex, highly-regulated organizations with international operations…

Continue Reading

ThursdayAug 31, 2017 9:20 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Announces Clinical Study of High Absorption TurboCBD™ Product

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced the world’s first clinical study on human volunteers of cannabidiol (CBD) within Lexaria’s TurboCBD™ product. The study, which aims to evaluate the effects of TurboCBD™ on both cardiovascular health and cognitive function, will have a double-blind and placebo controlled cross-over design measuring effects after a single dose, as well as seven days of daily dosing, in 24 volunteers. “Lexaria is proud to be advancing our collective knowledge of the benefits of CBD specifically showcasing the benefits of…

Continue Reading